Head-to-Head Comparison
GobyMeds vs Ro
Which GLP-1 provider is right for you? See how they compare on pricing, medications, insurance, and more.
GobyMeds
Transparent GLP-1 treatment with no hidden fees
8.7/10
$99–$1695/moasync4 meds
Ro
Modern healthcare, delivered
8.2/10
$149–$499/moInsuranceVideo & Async3 meds
Side-by-Side Comparison
Feature
GobyMeds
Ro
Our Rating
8.7/10
8.2/10
Monthly Price
$99–$1695/mo
$149–$499/mo
Consultation Fee
Free (included)
Free (included)
Insurance
No
Yes
Visit Type
async
Video & Async
# of Medications
4
3
Medications
Compounded Semaglutide, Compounded Tirzepatide, Wegovy (brand-name), Zepbound (brand-name)
Compounded Semaglutide, Wegovy (brand-name), Zepbound (brand-name)
States
Most US states
Most US states
Pros & Cons
GobyMeds
- Very affordable compounded semaglutide starting at $99/mo
- Both compounded and brand-name GLP-1 options
- Free consultation and free shipping
- No hidden fees or membership fees
- LegitScript certified for added trust
- Does not bill insurance directly
- Brand-name options (Wegovy, Zepbound) are significantly more expensive
- Newer platform with a smaller track record
Ro
- Offers both brand-name and compounded GLP-1 options
- Body Program includes metabolic lab testing
- Licensed providers in most states
- Medication delivered to your door
- Structured weight loss program with coaching
- Higher price point than some competitors
- Insurance coverage limited to certain plans
- May require lab work before starting
Our Verdict
GobyMeds is the budget option with compounded semaglutide from $99/mo and brand-name availability. Ro offers more structure through its Body Program with metabolic lab testing and accepts some insurance. Choose GobyMeds if price is your priority and you want a straightforward experience. Choose Ro if you want insurance coverage, lab work, and a more comprehensive weight loss program.
More Comparisons
This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer